Pharmaceutical Packaging Market Forecasts to 2028 – Global Analysis By Product (Primary, Tertiary and Secondary), By Material (Paper & Paperboard, Plastics & Polymers, Glass, Aluminum Foil, Parenteral Container, Blister Packing, Specialty Bags, Labels, Ca

Pharmaceutical Packaging Market Forecasts to 2028 – Global Analysis By Product (Primary, Tertiary and Secondary), By Material (Paper & Paperboard, Plastics & Polymers, Glass, Aluminum Foil, Parenteral Container, Blister Packing, Specialty Bags, Labels, Caps & Closures, Pills Box, Cartons, Fiber Drums, Metals, Bottles and Other Materials), By Type (Pouches & Sachets, Pre-filled Syringes, Jars & Canisters and Other Types), By Dosage Form (Oral, Topical and Other Dosage Forms), By Drug (Injectable Packaging, Pulmonary Drug Delivery Packaging, Transdermal Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging and Other Drugs), By End User (Contract Packaging, Pharmaceutical Manufacturing, Retail Pharmacy, Institutional Pharmacy, Pharmacies and Other End Users) and By Geography

According to Stratistics MRC, the Global Pharmaceutical Packaging Market is accounted for $116.8 billion in 2022 and is expected to reach $298.0 billion by 2028 growing at a CAGR of 16.9% during the forecast period. The storage and administration of medicinal products both benefit greatly from pharmaceutical packaging. Packaging is important in the marketing and promotion of brands in addition to the storage and protection of drugs.

According to IQVIA, 64.4% of the sales of new medicines launched on the market in 2016-2021 were in the US market, while the share of the European market was 16.8% (top 5 markets).

Market Dynamics

Driver:

Increase in demand from the pharmaceutical industry

The pharmaceutical sector is expanding rapidly, mostly in industrialized economies like the U.S., the U.K., and Germany, as well as in emerging economies like China, India, and Brazil. The increase is attributed to a number of factors, including an ageing population, an increase in technological advancements, a rise in healthcare awareness, the adoption of advanced manufacturing techniques, an increase in spending on public healthcare systems, and the implementation of new laws to stop the spread of infectious diseases.

Restraint

Inadequate access to proper healthcare

Poverty is an important barrier to accessing healthcare facilities in developing economies. The main obstacles preventing people from accessing healthcare services are money, lack of knowledge, awareness of fundamental medical procedures, and outdated equipment. In developing nations like India, South Africa, Brazil, and others, the market for pharmaceutical packaging is constrained by these issues. The majority of people in India continue to have health problems because access to care is limited and of poor quality.

Opportunity

Growing use of generic medicines in developing countries

Due to their low cost, generic pharmaceuticals are being used more frequently in developing nations, which will increase the demand for pharmaceutical packaging. A pharmaceutical drug is considered generic if it contains the same chemical components, dosage, intended use, adverse effects, and route of administration as the brand-name drug. To offer medical treatments at a lesser cost, many businesses are investing in the production of generic pharmaceuticals. Since it is necessary to pack and safeguard medicines during storage and transportation, this packaging plays a significant part in the manufacturing of generic medications.

Threat

Safeguarding against counterfeit items

When counterfeit medications are consumed, they could have negative side effects like allergic reactions or even death since they are produced with the wrong chemicals in the wrong quantities. Drug counterfeiting is reported in developing nations, including China, the Philippines, and Vietnam, which account for more than half of all reported cases. The availability of fake medications and fake packaging is growing as a result of the delays in the clearance of new drugs and their packaging brought on by expensive and lengthy product development cycles. These counterfeit items can cause allergic reactions, nausea, vomiting, and other adverse reactions in individuals.

Covid-19 Impact:

Due to the coronavirus, several industries are suffering, which causes a shortage of raw materials and disrupted supply chains. Companies associated with West Pharmaceutical Services were spared from the lockdown regulations, however, because of the importance of their operations to the community. The pharmaceutical business was established to produce healthcare items, and government assistance for prescription drugs and generic medications will contribute to the market's expansion.

The bottles segment is expected to be the largest during the forecast period

The bottles segment is expected to have the largest market share over the forecast period due to this material's lightweight, cheap, and simple-to-mould qualities. Packaging solid and liquid medications such as tablets, capsules, syrups, eye drops, and nose drops is also preferred to be performed in plastic bottles. Furthermore, because of their rigidity and superior barrier technologies, glass bottles are used to package liquid medications. Pharmaceutical solids like capsules and tablets are packaged in plastic bottles. However, bottles emerge in child-resistant packaging and are available in durable, user-friendly, and accessible sizes for end users.

The Oral segment is expected to have the highest CAGR during the forecast period

Because oral formulations are the most popular method of drug administration due to their simplicity, convenience, safety, and cost-effectiveness, the oral segment is anticipated to experience the highest CAGR over the projected period. Furthermore, this route of administration has higher patient compliance when compared to other modes of administration. The oral dosage forms make large-scale manufacturing simpler. In the global market, oral medication delivery packaging is the most important layout. However, the majority of pharmaceutical preparations are ingested orally as tablets, capsules, powders, liquids, and semi-liquids. Oral medication delivery is a choice due to its adaptability in dosage design and affordable manufacturing, which has further fueled the growth of oral drug delivery packaging.

Region with largest share

Asia Pacific is predicted to have the largest share during the forecast period, with the US serving as the main market, so Indian pharmaceuticals are shipped to more than 200 nations globally. The country is the top supplier of generic pharmaceuticals globally because generic drugs make up 20% of global exports. Moreover, hydroxychloroquine (HCQ), an anti-malarial medication deemed appropriate for treating COVID-19, and paracetamol were both exempt from export controls after the Indian government.

Region with highest CAGR

The Asia-Pacific region is expected to have lucrative growth over the projection period as it provides opportunities for the regional market owing to increasing investments and pharmaceutical manufacturing business expansions in China, Japan, and India. Apart from that, because of India's massive exports of pharmaceuticals to developed nations. In emerging markets, adherence to industrialised countries' packaging standards became crucial. Several offshore businesses are outsourcing their operations to nations like India and China in need of affordable solutions because emerging markets provide cost-effective, standardised packaging options.

Key players in the market

Some of the key players in Pharmaceutical Packaging market include Amcor Plc, Aptar Group Inc, Berry Global, Inc, CCL Industries Inc, Comar LLC, Drug Plastics Group, Graham Blow Pack Pvt. Limited, International Paper, Nipro Corporation, Nolato AB, Origin Pharma Packaging, Parekhplast India Limited, SCHOTT AG, SGD Pharma, Vetter Pharma International GmbH, WEST Pharmaceutical Services INC and WestRock.

Key Developments

In June 2022, Constantia Flexibles introduced a recycle-ready laminate with improved chemical resistance. The world’s third-largest flexible packaging manufacturer launched the first ready-to-be-recycled mono-material based on polypropylene (PP) with high chemical resistance for pharmaceutical products.

In May 2022, Bormioli Pharma, a manufacturer of glass and plastic primary packaging for pharmaceutical use, has announced the launch of EcoPositive, a label for all the company’s sustainable packaging offerings. This includes recycled glass and plastics, bio-based, biodegradable, or compostable plastic solutions, and advanced polymer products.

In April 2022, Amcor, a global leader in the design and manufacture of responsible packaging solutions, has announced the addition of a new, more sustainable High Shield laminate to its pharmaceutical packaging portfolio. New low-carbon, recyclable packaging options help on two fronts: meeting the high barriers and performance requirements demanded by the industry while supporting the recycling agenda of pharmaceutical companies.

Products Covered:
• Primary
• Tertiary
• Secondary

Materials Covered:
• Paper & Paperboard
• Plastics & Polymers
• Glass
• Aluminum Foil
• Parenteral Container
• Blister Packing
• Specialty Bags
• Labels
• Caps & Closures
• Pills Box
• Cartons
• Fiber Drums
• Metals
• Bottles
• Other Materials

Types Covered:
• Pouches & Sachets
• Pre-filled Syringes
• Jars & Canisters
• Other Types

Dosage Forms Covered:
• Oral
• Topical
• Other Dosage Forms

Drugs Covered:
• Injectable Packaging
• Pulmonary Drug Delivery Packaging
• Transdermal Drug Delivery Packaging
• Nasal Drug Delivery Packaging
• Ocular Drug Delivery Packaging
• Other Drugs

End Users Covered:
• Contract Packaging
• Pharmaceutical Manufacturing
• Retail Pharmacy
• Institutional Pharmacy
• Pharmacies
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements